News
3 Dividend Stocks With High Growth Potential
Great dividends or growth potential? Why decide? These 3 stocks have both.
a month ago•Lyndon Seitz
SMP
RM
GIC
3 New Strong Buy Ratings from Top-Rated Analysts: 10/03/2025
Forecasts suggest Biomarin (BMRN) could nearly double in the coming year. Find out why, and discover 2 more high-potential stocks.
a month ago•Mijuško Šibalić
NXT
GRDN
BMRN
Hot or Not, Stock Market Edition: 10/03/2025
People keep saying Nvidia’s (NVDA) big move is over … Yet it keeps making big moves. Plus, 3 other stocks to watch today.
a month ago•Jessie Moore
IBM
NVDA
MCD
NVO
Are We In a Stock Bubble?
There is something not quite right about this bull market. It is eerily similar to the internet bubble of the late 1990’s. Why is that? And how to navigate the bubble this time around? Read on for the answers…
a month ago•Steve Reitmeister
Biogen (BIIB): As Rates Fall, This Strong Buy-Rated Stock Could Benefit
Biotechs stand to benefit from falling rates — here’s why, and our top pick in the industry.
a month ago•Corbin Buff
BIIB
3 New Strong Buy Ratings from Top-Rated Analysts: 10/02/2025
These 3 stocks just got Strong Buy upgrades: Including Dycom (DY) and more.
a month ago•Mijuško Šibalić
DY
JBL
TEL
Hot or Not, Stock Market Edition: 10/02/2025
Broadcom (AVGO) is hot; Alibaba (BABA) is not. Plus, 2 more stocks we’re following today.
a month ago•Jessie Moore
AVGO
META
BABA
SHOP
2 Incredible Income Stocks for October
Rate cuts could create an incredible opportunity for these 2 income stocks.
2 months ago•Mijuško Šibalić
ALV
UAN
Hot or Not, Stock Market Edition: 10/01/2025
Salesforce (CRM) is hot; despite recent catalysts, Intel (INTC) is not. Here’s the story, plus 2 more stocks we’re watching.
2 months ago•Jessie Moore
CRM
JNJ
ARM
INTC
GSK Stock (GSK): A BIG Potential Winner When Pharma Tariffs Kick In
Pharma tariffs kick in October 1, 2025. Here’s why GSK (GSK) stock could be a big winner.
2 months ago•Mijuško Šibalić
GSK
3 New Strong Buy Ratings from Top-Rated Analysts: 09/30/2025
Today’s stocks to watch include Edwards Lifesciences (EW), Kinross Gold (KGC), and more.
2 months ago•Mijuško Šibalić
EW
KGC
CRL
Beware Growth Stocks!
Investors love growth stocks. Unfortunately for every success story like NVDA there is a myriad of failures leading to tremendous losses. Learn how to use the Zen Ratings to find stocks that enjoy more consistent growth…and more consistent outperformance.
2 months ago•Steve Reitmeister
NVDA
SRPT
CE
NMAX
5 Stocks to Watch: Week of 9/29/2025
1- Tutor Perini (NYSE: TPC)TPC found a place in our exclusive Zen Investor portfolio earlier this month. It’s the highest-rated stock in its industry — it’s also one of the highest-rated stocks overall.
2 months ago•Jessie Moore
BLBD
CCL
TPC
RL
LLY
3 Healthy Stocks With Recent Upgrades
These 3 stocks are solid picks during good and bad economic times — consider making space in your portfolio.
2 months ago•Lyndon Seitz
KR
NUTX
MIRM
3 New Strong Buy Ratings from Top-Rated Analysts: 09/26/2025
115 reasons to check out Tutor Perini (TPC) before the market close, plus 2 more high-conviction picks getting serious analyst love.
2 months ago•Mijuško Šibalić
WS
NBIX
TPC
Hot or Not, Stock Market Edition: 09/26/2025
Despite recent headlines, Amazon (AMZN) remains a Buy.
2 months ago•Jessie Moore
GILD
AMZN
QCOM
MSFT
Sibanye Stillwater (SBSW): This Year’s Quiet Superstar
Platinum has been the year’s quiet superstar. Here’s our top stock to watch in the industry.
2 months ago•Corbin Buff
SBSW
3 New Strong Buy Ratings from Top-Rated Analysts: 09/25/2025
The electrifying reason you should be watching Blue Bird (BLBD), plus 2 more Strong Buy-rated stocks
2 months ago•Mijuško Šibalić
LLY
CALX
BLBD
Hot or Not, Stock Market Edition: 09/25/2025
AppLovin (APP) is up 400% in the past year — but the party may be over. Plus, 3 more stocks we’re watching RN.
2 months ago•Jessie Moore
MU
APH
RTX
APP
3 Small Cap Strong Buys
We’ve unearthed 3 small cap stocks sending distinct “Strong Buy” signals. Get the tickers here.
2 months ago•Mijuško Šibalić
ALNT
AREN
BKTI
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.